Latest VR Adviser, LLC Stock Portfolio
$1.57Billion– No. of Holdings #35
VR Adviser, LLC Performance:
2024 Q2: -10.89%YTD: 9.28%2023: 5.35%
Performance for 2024 Q2 is -10.89%, and YTD is 9.28%, and 2023 is 5.35%.
About VR Adviser, LLC and 13F Hedge Fund Stock Holdings
VR Adviser, LLC is a hedge fund based in NEW YORK, NY. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.4 Billions. In it's latest 13F Holdings report, VR Adviser, LLC reported an equity portfolio of $1.6 Billions as of 30 Jun, 2024.
The top stock holdings of VR Adviser, LLC are , , FDMT. The fund has invested 21.3% of it's portfolio in APOGEE THERAPEUTICS INC and 6% of portfolio in ENLIVEN THERAPEUTICS INC.
The fund managers got completely rid off HILLEVAX INC (HLVX), CELCUITY INC (CELC) and IMMATICS N.V stocks. They significantly reduced their stock positions in MERUS N V (MRUS), ADVERUM BIOTECHNOLOGIES INC (ADVM) and TREVI THERAPEUTICS INC (TRVI). VR Adviser, LLC opened new stock positions in ERASCA INC (ERAS), CULLINAN THERAPEUTICS INC (CGEM) and ZURA BIO LTD. The fund showed a lot of confidence in some stocks as they added substantially to CENTURY THERAPEUTICS INC (IPSC), SPYRE THERAPEUTICS INC (AGLE) and COGENT BIOSCIENCES INC (COGT).
The top stock holdings of VR Adviser, LLC are , , FDMT. The fund has invested 21.3% of it's portfolio in APOGEE THERAPEUTICS INC and 6% of portfolio in ENLIVEN THERAPEUTICS INC.
The fund managers got completely rid off HILLEVAX INC (HLVX), CELCUITY INC (CELC) and IMMATICS N.V stocks. They significantly reduced their stock positions in MERUS N V (MRUS), ADVERUM BIOTECHNOLOGIES INC (ADVM) and TREVI THERAPEUTICS INC (TRVI). VR Adviser, LLC opened new stock positions in ERASCA INC (ERAS), CULLINAN THERAPEUTICS INC (CGEM) and ZURA BIO LTD. The fund showed a lot of confidence in some stocks as they added substantially to CENTURY THERAPEUTICS INC (IPSC), SPYRE THERAPEUTICS INC (AGLE) and COGENT BIOSCIENCES INC (COGT).
VR Adviser, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
VR Adviser, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that VR Adviser, LLC made a return of -10.89% in the last quarter. In trailing 12 months, it's portfolio return was 19.49%.
New Buys
| Ticker | $ Bought |
|---|---|
| erasca inc | 38,270,300 |
| cullinan therapeutics inc | 24,066,600 |
| zura bio ltd | 21,081,100 |
| perceptive cap solutions cor | 7,545,000 |
| arca biopharma inc | 3,318,220 |
| casi pharmaceuticals inc | 614,273 |
New stocks bought by VR Adviser, LLC
Additions
| Ticker | % Inc. |
|---|---|
| century therapeutics inc | 58.27 |
| spyre therapeutics inc | 23.65 |
| cogent biosciences inc | 10.82 |
| engene holdings inc | 10.14 |
| applied therapeutics inc | 5.16 |
| praxis precision medicines i | 0.00 |
Additions to existing portfolio by VR Adviser, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| merus n v | -29.44 |
| adverum biotechnologies inc | -5.74 |
| trevi therapeutics inc | 0.00 |
VR Adviser, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| lyra therapeutics inc | -16,023,300 |
| hillevax inc | -34,507,200 |
| immatics n.v | -18,392,500 |
| celcuity inc | -20,952,000 |
| acelyrin inc | -6,325,510 |
| mineralys therapeutics inc | -7,172,200 |
| cg oncology inc | -15,365,000 |
| eyepoint pharmaceuticals inc | -5,167,500 |
VR Adviser, LLC got rid off the above stocks
Sector Distribution
VR Adviser, LLC has about 60.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 60.5 |
| Others | 39.5 |
Market Cap. Distribution
VR Adviser, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 46.7 |
| UNALLOCATED | 39.5 |
| MID-CAP | 9.6 |
| MICRO-CAP | 3.9 |
Stocks belong to which Index?
About 44% of the stocks held by VR Adviser, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 56 |
| RUSSELL 2000 | 44 |
VR Adviser, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of VR Adviser, LLC
VR Adviser, LLC has 35 stocks in it's portfolio. About 64.6% of the portfolio is in top 10 stocks. FDMT proved to be the most loss making stock for the portfolio. MRUS was the most profitable stock for VR Adviser, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABIO | arca biopharma inc | 0.21 | 866,375 | 3,318,220 | new | |||
| ADVM | adverum biotechnologies inc | 0.64 | 1,467,050 | 10,063,900 | reduced | -5.74 | ||
| AGLE | spyre therapeutics inc | 4.02 | 2,685,450 | 63,134,900 | added | 23.65 | ||
| APLT | applied therapeutics inc | 2.84 | 9,542,870 | 44,565,200 | added | 5.16 | ||
| AQST | aquestive therapeutics inc | 0.92 | 5,555,560 | 14,444,400 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 1.06 | 627,788 | 16,711,700 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 2.09 | 3,608,640 | 32,838,700 | unchanged | 0.00 | ||
| CABA | cabaletta bio inc | 0.74 | 1,563,950 | 11,698,400 | unchanged | 0.00 | ||
| CELC | celcuity inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CGEM | cullinan therapeutics inc | 1.53 | 1,379,960 | 24,066,600 | new | |||
| COGT | cogent biosciences inc | 3.05 | 5,684,170 | 47,917,500 | added | 10.82 | ||
| DYN | dyne therapeutics inc | 4.89 | 2,173,910 | 76,717,400 | unchanged | 0.00 | ||
| ERAS | erasca inc | 2.44 | 16,216,200 | 38,270,300 | new | |||
| EWTX | edgewise therapeutics inc | 2.08 | 1,818,180 | 32,745,500 | unchanged | 0.00 | ||
| EYPT | eyepoint pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FDMT | 4d molecular therapeutics in | 5.88 | 4,400,000 | 92,356,000 | unchanged | 0.00 | ||
| HLVX | hillevax inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IPSC | century therapeutics inc | 0.88 | 5,389,260 | 13,742,600 | added | 58.27 | ||
| KALV | kalvista pharmaceuticals inc | 4.69 | 6,249,730 | 73,621,800 | unchanged | 0.00 | ||
| LYRA | lyra therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||